FDA panel votes in favor of efficacy data for Eli Lilly Alzheimer's drug - Reuters

Reuters | June 10, 2024, 3:48 p.m. | Original
FDA panel votes in favor of efficacy data for Eli Lilly Alzheimer's drug Reuters
France's far-right National Rally projected to win snap election without absolute majority - Reuters Activist investor Elliott calls for Southwest Airlines leadership, board changes - Reuters